Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation

Por Heitman, Steven J., Hilsden, Robert J., Au, Flora, Dowden, Scot, Manns, Braden J.
Publicado em 2010

Correction: Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation

Por Heitman, Steven J., Hilsden, Robert J., Au, Flora, Dowden, Scot, Manns, Braden J.
Publicado em 2012

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

Por Bigam David, Butts Charles, Dixon Elijah, Sutherland Francis, Dowden Scot, Bathe Oliver F, Walley Barb, Ruether Dean, Ernst Scott
Publicado em 2004-07-01

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

Por Bathe, Oliver F, Dowden, Scot, Sutherland, Francis, Dixon, Elijah, Butts, Charles, Bigam, David, Walley, Barb, Ruether, Dean, Ernst, Scott
Publicado em 2004

nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial

Por Tehfe, Mustapha, Dowden, Scot, Kennecke, Hagen, El-Maraghi, Robert, Lesperance, Bernard, Couture, Felix, Letourneau, Richard, Liu, Helen, Romano, Alfredo
Publicado no Adv Ther (2016)

Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial

Por Tehfe, Mustapha, Dowden, Scot, Kennecke, Hagen, El-Maraghi, Robert, Lesperance, Bernard, Couture, Felix, Letourneau, Richard, Liu, Helen, Romano, Alfredo
Publicado no Adv Ther (2016)

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

Por Bathe, Oliver F, Ernst, Scott, Sutherland, Francis R, Dixon, Elijah, Butts, Charles, Bigam, David, Holland, David, Porter, Geoffrey A, Koppel, Jennifer, Dowden, Scot
Publicado em 2009

Population-based review of the outcomes following hepatic resection in a Canadian health region

Por Dixon, Elijah, Bathe, Oliver F., McKay, Andrew, You, Isabelle, Dowden, Scot, Sadler, David, Burak, Kelly W., McKinnon, J. Gregory, Miller, Walter, Sutherland, Francis R.
Publicado em 2009

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Por Von Hoff, Daniel D., Ervin, Thomas, Arena, Francis P., Chiorean, E. Gabriela, Infante, Jeffrey, Moore, Malcolm, Seay, Thomas, Tjulandin, Sergei A., Ma, Wen Wee, Saleh, Mansoor N., Harris, Marion, Reni, Michele, Dowden, Scot, Laheru, Daniel, Bahary, Nathan, Ramanathan, Ramesh K., Tabernero, Josep, Hidalgo, Manuel, Goldstein, David, Van Cutsem, Eric, Wei, Xinyu, Iglesias, Jose, Renschler, Markus F.
Publicado no N Engl J Med (2013)